Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis c
Symptom C0019204|hepatocellular carcinoma
Sentences 121
PubMedID- 25654412 Materials and methods: all patients who had undergone transplant for hepatocellular carcinoma associated with hepatitis c virus from 2002 to 2012 were evaluated retrospectively.
PubMedID- 19879972 Background & aims: the effects of antiviral therapy on prevention of hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv)-related cirrhosis are unclear.
PubMedID- 23463401 hepatocellular carcinoma in patients with chronic hepatitis c virus infection in the asia-pacific region.
PubMedID- 25667487 Patients and methods: serum samples were collected preoperatively from 125 patients with hepatocellular carcinoma associated with hepatitis c virus infection who underwent curative hepatectomy.
PubMedID- 22875473 Background: we investigated whether the administration of maintenance doses of interferon prevented hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.
PubMedID- 24462733 A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis c and cirrhosis.
PubMedID- 25657603 In a recent report from our institution, we identified over a three-year period 3% (9/298) of ltx patients who developed severe hf after ltx.62 in these nine patients, etiology of liver failure was hepatitis c with hepatocellular carcinoma in four, hemochromatosis in four (with one showing evidence of iron deposition in the heart on biopsy), and one with primary biliary cirrhosis.
PubMedID- 22096937 Antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related chronic hepatitis and cirrhosis.
PubMedID- 21253791 Several noncurative treatments also appear to reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 24703510 Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis c virus infection.
PubMedID- 23426277 Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c.
PubMedID- 23497542 In japan, chronic hepatitis c is associated with 90% of hepatocellular carcinoma (hcc) cases, and hcc is associated with liver cirrhosis in 85% of all cases.
PubMedID- 25650331 Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.
PubMedID- 25788045 Methods: serum ferritin was measured in 487 chronic hepatitis c patients without history of hepatocellular carcinoma (hcc) after excluding patients in phlebotomy, those with overt chronic gastrointestinal bleeding and those who achieved sustained virological response before enrollment.
PubMedID- 21520203 Occult hepatitis b virus infection and hepatocellular carcinoma development in patients with chronic hepatitis c.
PubMedID- 25743000 Objective: to determine the impact of phlebotomy on the laboratory values and the incidence of hepatocellular carcinoma (hcc) in patients with hepatitis c.
PubMedID- 26017875 Alterations of wnt/beta-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis c virus.
PubMedID- 23065464 Data on the safety and efficacy of combination therapy in chronic hepatitis c patients with hepatocellular carcinoma (hcc) is scarce and even more so in hiv/hcv co-infected subjects.
PubMedID- 21766498 Purpose: the aim of this study was to compare patients with hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection with patients with liver cirrhosis associated with hcv virus infection.
PubMedID- 20458764 Aim: to elucidate the role of insulin resistance (ir) and serum adiponectin level in hepatocellular carcinoma (hcc) associated with chronic hepatitis c.
PubMedID- 25559606 The effect of hiv viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis c and hiv coinfection.
PubMedID- 22004425 Genetic risk of hepatocellular carcinoma in patients with hepatitis c virus: a case control study.
PubMedID- 24662676 Given the role of hepatocellular cd81 in hcv infection and the association of chronic hepatitis c with hepatocellular carcinoma (hcc) there is a growing interest in studying the function of cd81 in hepatocytes.
PubMedID- 22212964 Viral hepatitis among somali immigrants in minnesota: association of hepatitis c with hepatocellular carcinoma.
PubMedID- 23122451 Is serum level of methylated rassf1a valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis c.
PubMedID- 21133598 Comparison of serum survivin and alpha fetoprotein in egyptian patients with hepatocellular carcinoma associated with hepatitis c viral infection.
PubMedID- 21278701 Conclusions: the incidence of hepatocellular carcinoma associated with hepatitis c infection decreased after 2001 in kyushu area.
PubMedID- 24843320 Previous reports have shown that interferon (ifn)-based therapy decreases the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection.
PubMedID- 21331763 Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 21170963 Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc).
PubMedID- 22410057 The primary liver diseases included hepatitis b virus (n=2), alcoholic liver cirrhosis (n=2), cryptogenic liver disease (n=1), and hepatitis c virus with hepatocellular carcinoma (n=1).
PubMedID- 26394142 End-stage liver disease and hepatocellular carcinoma due to hepatitis c virus (hcv) infection constitute one of the main indications for liver transplantation (lt) worldwide 1.
PubMedID- 21056500 Background & aims: evidence on the efficacy of antiviral treatment in chronic hepatitis c (chc) patients with hepatocellular carcinoma (hcc) after curative treatment is scarce.
PubMedID- 21461077 Background/aims: despite great progress, antiviral treatment for chronic hepatitis c in patients with prior hepatocellular carcinoma (hcc) has been rarely investigated.
PubMedID- 26191473 In addition, dm has been suggested to enhance the development of hepatocellular carcinoma in patients with chronic hepatitis c (kawamura et al.
PubMedID- 24393884 Case 1 involved a 63-year-old woman who had multiple hepatocellular carcinomas (hcc) associated with hepatitis c virus infection.
PubMedID- 21129375 Background & aims: interferon reportedly decreases the incidence of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.
PubMedID- 22207106 Randomized controlled trials also confirm that glycyrrhizin and its derivatives can improve the hepatocellular injury in chronic hepatitis b or c patients, and reduce the risk for hepatocellular carcinoma in patients with hepatitis c virus-induced cirrhosis .
PubMedID- 23509319 Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 25912838 We assessed the effects of hvpg and svr on the risk of liver decompensation, hepatocellular carcinoma, and/or death in patients with hepatitis c-related cirrhosis.
PubMedID- 20981260 A 73-year-old man with a history of hepatocellular carcinoma associated with hepatitis c virus-related cirrhosis was referred to the department of urology because a thickened wall of the urinary bladder was incidentally detected by computed tomography (ct).
PubMedID- 20883676 Background: there are few blood tests for an efficient detection of hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection.
PubMedID- 26301052 hepatitis c infection can lead to cirrhosis and hepatocellular carcinoma and it is an important cause of mortality and morbidity.
PubMedID- 21610221 Background: this study explores the influence of two functional genetic polymorphisms in the regulated on activation in normal t-cell expressed and secreted(rantes) promoter on the risk of hepatocellular carcinoma (hcc) occurrence in patients with alcoholic or hepatitis c virus (hcv)-related cirrhosis.
PubMedID- 23849467 The present cross-sectional study investigated 12 perfluoroalkyl substances (pfass) in serum (n=79) and liver (n=66) samples from patients who had undergone liver transplantation for a range of conditions, such as hepatocellular carcinoma (hcc), cirrhosis due to chronic hepatitis c viral infection (hcv), both hcc and hcv, amyloidosis or acute liver failure.
PubMedID- 22588449 Skull metastasis from hepatocellular carcinoma with hepatitis c.
PubMedID- 20404016 The incidence of hepatocellular carcinoma is rising due to alcohol drinking, hepatitis c viral infection and metabolic syndrome.
PubMedID- 21718500 Reported a correlation between a diabetic pattern of the 75 g oral glucose tolerance test ogtt and hepatocarcinogenesis and considered it a significant risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus .
PubMedID- 23657093 Untreated chronic hepatitis c can lead to cirrhosis, hepatocellular carcinoma and death 2.
PubMedID- 21931376 Objectives: prospective studies of serum hepatocellular carcinoma (hcc) biomarkers in patients with advanced hepatitis c are lacking.

Page: 1 2 3